Safety Surveillance Principal Specialist

.

Your impact begins here

As Safety Surveillance Principal Specialist, you will be the safety lead for several products in Novo’s early pipeline, working where non-clinical and clinical development meet. You will turn emerging data into a clear early safety profile and shape decisions for first-in-human and early clinical studies. Your scientific judgement will help protect the people taking part in these studies and give development teams the clarity to move at pace.

What you’ll bring

You are a scientist first. You are confident, outgoing and driven, and you want to be in the room where early safety decisions are made.

• A PhD, MD, DVM, MSc Pharm or equivalent in Medicine or Natural Sciences, with extensive experience in pharmacovigilance or early-phase pharmaceutical development.
• A solid understanding of drug development processes, global regulatory requirements and GxP standards.
• A strong grasp of medical concepts, disease mechanisms and scientific methodology. You use data to build scientific understanding, rather than letting the data lead you.
• The ability to identify challenges, shape strategies and turn them into clear, actionable steps.
• Confidence to take informed scientific risks and make a call, while never compromising on patient safety.
• Excellent collaboration and communication skills, with the ability to guide and influence others through mentorship and informal leadership.
• A self-driven, ethical and adaptable approach. You work independently, address issues proactively and stay flexible when priorities change.

What you’ll do

• Own the early safety profile of products, evaluating emerging pre-clinical and clinical safety data to guide patient surveillance and business decisions.
• Lead the resolution of complex safety challenges and provide strong scientific and medical input across development activities.
• Shape study designs, clinical protocols and benefit-risk assessments, working to ambitious development timelines.
• Chair a cross-functional drug safety committee and represent Safety Surveillance in key cross-functional teams.
• Drive initiatives that strengthen scientific, strategic and operational excellence within Safety Surveillance.

Who you’ll work with

You will join Safety Surveillance Early Development, part of Global Patient Safety in Research & Development. It is a team of 8 colleagues in Denmark, and it handles all First Human Dose (FHD) studies across all indications at Novo. The team provides scientific safety expertise to early-stage projects, contributes to safety strategy and supports protocol review, risk assessments, early signal detection and cross-functional safety forums.

Your closest partners will be the non-clinical project manager, the medical specialist and the clinical pharmacologist. Together you will design studies that are scientifically strong and move quickly. You will also work with skilled colleagues across Non-clinical and Clinical Development, and across several therapeutic areas.

The environment is dynamic, collaborative and highly engaged. Colleagues share scientific insights, speak openly and support one another when evaluating complex safety data. Everyone is focused on doing what is best for the people we serve.

What you can expect here

You will have real ownership. As safety lead, you will be trusted to work independently, make your voice heard and influence decisions that guide early development. You will keep learning from colleagues across Non-clinical and Clinical Development, and you will help strengthen a culture of knowledge sharing and openness in the team.

Salary: For this role, the Annual Base Salary ranges from 847,000 to
1,245,100 DKK, corresponding to the level of the position. The placement within the salary range will be assessed during the recruitment process based on the candidate's skills, competencies, knowledge and relevant experience.

Incentives and Benefits: The salary package may include short-term and/or long-term incentives as well as other employee benefits based on position level, location, functional area and relevant market benchmarks.

Learn more about our Reward Philosophy here

Start now

Your impact begins today. Please apply by 25 November 2026. We review applications on an ongoing basis, so we encourage you to apply as soon as possible.

We are an equal opportunities employer and are committed to an inclusive recruitment process and equality of opportunity for all applicants.